Chronic HCV Linked to Doubled Risk of Pancreatic Cancer
Here’s a breakdown of the key findings and implications from the provided text:
Key Findings:
* HCV & PDAC Risk: both having a chronic, untreated Hepatitis C Virus (HCV) infection and simply being exposed to HCV are linked to an increased risk of developing Pancreatic ductal Adenocarcinoma (PDAC – a type of pancreatic cancer).
* Chronic HCV: 76% increased risk (HR = 1.76)
* HCV Exposure: 18% increased risk (aHR = 1.18)
* Genotype Matters: Certain HCV genotypes appear to carry a higher risk than others.
* Genotype 3: Highest risk (2.02 times higher)
* Genotype 1: Also high risk (1.75 times higher)
* Genotype 2: Lowest risk among those studied (1.35 times higher)
Implications & Future Research:
* Treatment Potential: Researchers are investigating whether treating HCV with direct-acting antivirals can reduce the risk of developing PDAC.This is a key next step.
* Biological Mechanism: Scientists want to understand how HCV infection increases PDAC risk – identifying the underlying biological mechanisms.
* Addressing Limitations: The study was conducted on a predominantly male veteran population with potential exposure to toxins. Future research needs to account for these factors.
Contact Information:
* Louise L. Wang, MD, MSc (lead researcher) can be contacted at: louise.wang@yale.edu
Source:
* Published by Healio Gastroenterology.
Healio AI Promotion: The article also includes a promotion for Healio AI, a tool that provides access to medical knowledge from sources like PubMed, clinical guidelines, and Healio’s news coverage.